Funded Tech Companies

InProTher

InProTher is a biopharmaceutical growth company, based in Copenhagen. Financial backing came from European Innovation Council Fund and private investors.

Company Overview

Company Name
InProTher
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Novo Nordisk Bioinnovation Institute Ole Maaløes Vej 3
Copenhagen, 2200
DK
Email Address

Company Background Information

Overview
InProTher is developing first-in-class immunotherapies against cancer and has pre-clinical proof of concept for broad and curative cancer therapy. Treated animals eliminate their tumors and become resistant to challenge from administered cancer cells. A combination with immune checkpoint inhibitors makes the effect complete in animal models. InProTher's research is based upon research by Associate Professor Peter Johannes Holst and colleagues and international collaborators.
Profile
InProTher LinkedIn Company Profile
Social Media
InProTher Company Twitter Account
Company News
InProTher News
Facebook
InProTher on Facebook
YouTube
InProTher on YouTube
Last Transaction
5/24/2023

Financing History

Date
Type
Amount
Venture Equity
$6,438,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jordi Naval
  Jordi Naval LinkedIn Profile  Jordi Naval Twitter Account  Jordi Naval News  Jordi Naval on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Inpria | inQuba

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary